ライフサイエンスコーパス: respiratory infection

1 age or a less severe syndrome, such as upper respiratory infection).

2 lethal challenge mouse model of pneumococcal respiratory infection.

3 gment pathogen-based tests to diagnose viral respiratory infection.

4 models of P. aeruginosa intraperitoneal and respiratory infection.

5 od of 6.99 years, 1,282 people died of lower respiratory infection.

6 naling axis they activate to protect against respiratory infection.

7 t important challenge to understanding lower respiratory infection.

8 urine host's gene expression and response to respiratory infection.

9 CD11b(+) macrophages in the lungs following respiratory infection.

10 ontrol IAV replication and succumb to lethal respiratory infection.

11 pes and organ systems dictate the outcome of respiratory infection.

12 ovalbumin-induced AAD with C muridarum (Cmu) respiratory infection.

13 ping host immunity and modifying the risk of respiratory infection.

14 ildren presenting to the hospital with acute respiratory infection.

15 ibility of home-based, remote monitoring for respiratory infections.

16 d in vivo using nasal aspirates during viral respiratory infections.

17 ubjects and are at greater risk for invasive respiratory infections.

18 ating viruses that are responsible for acute respiratory infections.

19 od smoke, is associated with increased lower respiratory infections.

20 rsonnel (HCP) from acquiring workplace viral respiratory infections.

21 ays condition that can be exacerbated during respiratory infections.

22 phopenia, myeloid dysfunction, and recurrent respiratory infections.

23 ary cells and may increase susceptibility to respiratory infections.

24 iseases, including sarcoidosis; and selected respiratory infections.

25 aryngeal niche, a reservoir for ME and upper respiratory infections.

26 ng antibiotic therapy in patients with acute respiratory infections.

27 responses as a therapeutic modality to treat respiratory infections.

28 sed guidelines can reduce antibiotic use for respiratory infections.

29 l of individuals with high susceptibility to respiratory infections.

30 entification of these causative pathogens in respiratory infections.

31 Disruption of ciliary flow can lead to respiratory infections.

32 monologist views the conceptual framework of respiratory infections.

33 phages are the first line of defense against respiratory infections.

34 altophilia may have clinical significance in respiratory infections.

35 B) may confer nonspecific protection against respiratory infections.

36 tant feature of diabetes that predisposes to respiratory infections.

37 nza; tuberculosis; and other lower and upper respiratory infections.

38 f 18 viral and 3 bacterial pathogens causing respiratory infections.

39 have enduring effects on host resistance to respiratory infections.

40 that may affect the host's susceptibility to respiratory infections.

41 ic signal representative of a range of acute respiratory infections.

42 lamydia pneumoniae causes community-acquired respiratory infections.

43 n influenza A viruses and human samples with respiratory infections.

44 of particular importance as a source of many respiratory infections.

45 t to distinguish clinically from other acute respiratory infections.

46 improving clinical outcomes following severe respiratory infections.

47 articipated in a prospective cohort study of respiratory infections.

48 iratory samples from patients suspected with respiratory infections.

49 9 infection and 42 patients with other viral respiratory infections.

50 mates are linked to the seasonality of viral respiratory infections.

51 ng ever-smokers associated with infant lower respiratory infection (-108.2 ml; P = 0.001) and home ov

52 mission diagnoses of patients with AIDS were respiratory infection (28.6%) and sepsis (16.9%), which

53 Of 6001 medically attended respiratory infections, 302 (5%) were caused by RSV.

54 irth defects (39 [13%] of 304 deaths), lower respiratory infection (37 [12%]), and HIV (35 [12%]).

55 by cerebrovascular disease (7.5%) and lower respiratory infections (4.9%).

56 hs old and were most commonly diagnosed with respiratory infection (47.7%), malaria (29.7%), and/or g

57 otherapy in patients in the D-VMP group were respiratory infections (54 [19%] of 278 patients had upp

58 IDS (12.6%), diarrheal disease (8.7%), acute respiratory infections (7.9%), injuries (7.9%), and mali

59 Our results help to understand how transient respiratory infections, a common occurrence in human lif

60 Respiratory infections account for a large percentage of

61 iddle East respiratory syndrome severe acute respiratory infection (adjusted odds ratio, 5.87; 95% CI

62 oup were hospitalized for treatment of acute respiratory infection (adjusted risk ratio, 0.86; 95% CI

63 virus (RSV) is a major cause of acute lower respiratory infection (ALRI) in young children aged <5 y

64 uenza virus is a common cause of acute lower respiratory infection (ALRI) in young children.

65 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in 55 000 to 199

66 fy and investigate children with acute lower respiratory infection (ALRI).

67 s for hospitalised children with acute lower respiratory infection (ALRI).

68 s a common virus associated with acute lower respiratory infections (ALRIs) in children.

69 n viral pathogen associated with acute lower respiratory infections (ALRIs), with significant childho

70 species, are the causative agents of severe respiratory infections among children and are linked to

71 effect of facemasks and respirators against respiratory infections among healthcare workers.

72 the linked epidemiological dynamics of viral respiratory infections, an important step towards improv

73 fluenza-confirmed hospitalizations for acute respiratory infection and 13 of 294 (4.4%) influenza-con

74 DM allergen, likely predisposing neonates to respiratory infection and altering long-term pulmonary h

75 ate genes and 10 phenotypes related to viral respiratory infection and asthma control were examined i

76 RSV is the most common cause of acute lower respiratory infection and bronchiolitis.

77 inpatient admission, and treatment for acute respiratory infection and diarrhoea), financial protecti

78 against antibiotic-treated episodes of acute respiratory infection and diarrhoea, respectively, in ag

79 with reduced time in the hospital with acute respiratory infection and reduced diastolic blood pressu

80 n PCT subjects with Streptococcus pneumoniae respiratory infection and those with E. coli urogenital

81 The early phenotype was more likely to have respiratory infections and acute exacerbations at baseli

82 suggests associations with increased risk of respiratory infections and all-cause mortality.

83 agnoses despite hypotheses relating ozone to respiratory infections and allergic responses.

84 Influenza A virus (IAV) causes severe respiratory infections and alveolar epithelial damage re

85 t can cause a multitude of diseases, such as respiratory infections and conjunctivitis.

86 eutrophil migratory accuracy with age during respiratory infections and determine if and how a statin

87 Infants suffer disproportionately from respiratory infections and generate reduced vaccine resp

88 n important first-line defence against viral respiratory infections and has been linked to the pathog

89 Human bocavirus 1 (HBoV1) causes severe respiratory infections and HBoV2 to HBoV4 cause gastroin

90 ess personal protective equipment to prevent respiratory infections and illness conducted from 2011 t

91 ch (NIHR) Health Protection Research Unit in Respiratory Infections and NIHR Imperial Biomedical Rese

92 lated inflammasome activation contributes to respiratory infections and pathologic airway inflammatio

93 is a potential therapeutic target for upper respiratory infections and that flavones may have clinic

94 ovide insight into the pathogenesis of viral respiratory infections and virus-induced exacerbations o

95 the incidence of tuberculosis disease, acute respiratory infection, and adverse events.

96 (GP) data on attendance for care from acute respiratory infection, and virological testing of acute

97 over several years on cardiovascular events, respiratory infections, and falls/fractures.

98 were collected during maternal acute febrile respiratory infections, and from infants with any respir

99 ur in chronic obstructive pulmonary disease, respiratory infections, and neutrophilic asthma.

100 [95% confidence interval {CI}, .76-.95]) and respiratory infection (aOR, 0.82 [95% CI, .75-.90]) and

101 Respiratory infections are common precursors to asthma e

102 erapeutic interventions for the treatment of respiratory infections are hampered by the evolution of

103 Viral respiratory infections are risk factors for cardiovascul

104 Viral respiratory infections are usually mild and self-limitin

105 er 2016, we conducted surveillance for acute respiratory infection (ARI) among ~12 000 adults (>=18 y

106 Previous studies have suggested that acute respiratory infection (ARI) and nonsteroidal anti-inflam

107 ty of influenza-like illness (ILI) and acute respiratory infection (ARI) than non-shift workers.

108 med pneumococcal meningitis at HCH and acute respiratory infection (ARI) trends using Ministry of Hea

109 We find that malaria, acute respiratory infection (ARI), and diarrhea incidence are

110 viral pathogens, causing epidemics of acute respiratory infection (ARI), especially bronchiolitis an

111 amin D status are at increased risk of acute respiratory infection (ARI), randomized controlled trial

112 east milk pre-F antibodies against RSV acute respiratory infection (ARI).

113 2 million annual episodes of seasonal acute respiratory infections (ARI) and approximately 500,000 d

114 uenza Vaccine Evaluation (HIVE) study, acute respiratory infections (ARI) have been identified in chi

115 al virus (RSV) is the leading cause of acute respiratory infections (ARI) in hospitalized children.

116 iratory visits, including specifically acute respiratory infections (ARI), asthma, pneumonia, chronic

117 h 2016 to assess reported diarrhea and acute respiratory infections (ARIs) among children <5 years in

118 Acute respiratory infections (ARIs) are thought to play an imp

119 apid diagnostic test (RDT), diarrhoea, acute respiratory infections (ARIs), stunting, wasting, underw

120 ts to advance antiviral mAbs for other acute respiratory infections (ARIs), we highlight the challeng

121 further developed for the treatment of both respiratory infection as well as neuronal infection.

122 human nasopharynx and can cause a variety of respiratory infections as well as invasive diseases, inc

123 We separately estimated the rate of respiratory infection associated with increased concentr

124 Respiratory infections associated with HAdV-7 can be sev

125 5, and all ages) and by outcome group (acute respiratory infection, asthma, chronic obstructive pulmo

126 unced associations were seen for acute upper respiratory infections at multiple and unspecified sites

127 infection, and virological testing of acute respiratory infections at the GP.

128 ing treatment for asthma, and without recent respiratory infections (baseline COPD was not an exclusi

129 d from healthy individuals and patients with respiratory infections before the first outbreak of coro

130 coccus pneumoniae (Spn) is a common cause of respiratory infection, but also frequently colonizes the

131 ibutes to TCD8 impairment during viral lower respiratory infection, but how it regulates TCD8 impairm

132 The microbiota promotes resistance to respiratory infection, but the mechanistic basis for thi

133 cessary outpatient prescribing against acute respiratory infections, but data are conflicting on sust

134 ) is associated with increased risk of acute respiratory infections, but its association with long-te

135 tibody protects against RSV-associated lower respiratory infections, but placental malaria (PM) and m

136 mbers of the microbiota that protect against respiratory infection by the major human pathogens Strep

137 lisation rates of influenza-virus-associated respiratory infections by severity, case ascertainment,

138 Viral respiratory infections can cause acute wheezing illnesse

139 Severe respiratory infections can result in acute respiratory d

140 ns, chronic respiratory diseases, diarrhoea, respiratory infections, cancer, stroke, road traffic acc

141 Furthermore, the severe acute respiratory infection cases with unknown aetiology were

142 navirus disease 2019 (COVID-19), an emerging respiratory infection caused by the introduction of a no

143 r for treating complicated urinary tract and respiratory infections caused by multidrug-resistant bac

144 Similar observations were made for acute respiratory infections caused by other coronaviruses (se

145 ored in human for prevention or treatment of respiratory infections caused by RSV.

146 causative agent of whooping cough, a serious respiratory infection causing hundreds of thousands of d

147 Diphtheria is generally an acute respiratory infection, characterized by the formation of

148 and symptoms overlap those of other seasonal respiratory infections concurrently circulating in the p

149 n particular smokers are more susceptible to respiratory infections contributing to acute exacerbatio

150 s were unchanged when syndromic severe acute respiratory infection criteria were applied instead of c

151 to be due to a cold, otitis media, an upper respiratory infection, croup, asthma, bronchitis, bronch

152 The risk of SSTI and respiratory infection decreased after bariatric surgery

153 For many bacterial respiratory infections, development of (severe) disease

154 comparison group was defined by later upper respiratory infection diagnosis.

155 ) or systemic adverse event (fever, allergy, respiratory infections, diarrhoea, and vomiting).

156 Pathognomonic clinical variables of respiratory infection did not differ among groups.

157 of 135 previously healthy infants with acute respiratory infection due to human rhinovirus (HRV; n =

158 ese features with patients with severe acute respiratory infection due to other etiologies.

159 lesser extent, among children who had had a respiratory infection during the first year of life (haz

160 S. pneumoniae infection, which suggests that respiratory infections even late after traumatic brain i

161 ischaemic heart disease for males and lower respiratory infection for females.

162 This study analyzed 34 459 patients with respiratory infection from 2009 to 2018, of whom 8011 we

163 iddle East respiratory syndrome severe acute respiratory infection from other etiologies; therefore,

164 of critically ill patients with severe acute respiratory infection from the Middle East respiratory s

165 onin-guided treatment in patients with acute respiratory infections from different clinical settings.

166 ve pulmonary disease, lung cancer, and lower respiratory infections from epidemiological studies usin

167 irus (RSV) in adults hospitalized with acute respiratory infections, guidelines for the diagnosis and

168 iddle East respiratory syndrome severe acute respiratory infection had more severe hypoxemic respirat

169 eolar development and increased morbidity to respiratory infections, had reduced IGF1 concentrations

170 inate infectious communities associated with respiratory infections has direct relevance to treatment

171 onaviruses (CoV) that cause mild to moderate respiratory infections (HCoV-229E, HCoV-NL63, HCoV-OC43,

172 roportion to global estimates of acute lower respiratory infection hospitalizations among children ag

173 s between bacteria govern the progression of respiratory infections; however, the mechanisms underpin

174 n lead to adverse health outcomes, including respiratory infections, impaired lung function, cardiac

175 th asthma (RR 1.23, 95% CI 1.11-1.36), acute respiratory infection in both adults (1.53, 1.22-1.93) a

176 nasal swabs as potential biomarkers of viral respiratory infection in children.

177 espiratory syncytial virus (RSV) cause lower respiratory infection in infants and young children.

178 NALE: Bronchiolitis is the most common lower respiratory infection in infants; however, it remains un

179 ional antibiotic use for patients with acute respiratory infection in low-income and middle-income co

180 sol delivery of B. pseudomallei to establish respiratory infection in mice and studied CPS I in the c

181 ced ability to prevent or treat lethal viral respiratory infection in mice, with increased maturation

182 o be efficacious against influenza and other respiratory infections in a variety of preclinical and c

183 irus (HMPV) are two of the leading causes of respiratory infections in children and elderly and immun

184 um is occasionally used to investigate lower respiratory infections in children but has not been wide

185 al and global burden of influenza-associated respiratory infections in children under 5 years from a

186 nd mortality from influenza-virus-associated respiratory infections in children under 5 years in 2018

187 show that Aspergillus species are prevalent respiratory infections in children with cystic fibrosis

188 nza virus and other respiratory pathogens to respiratory infections in community-dwelling older adult

189 Frequent viral lower respiratory infections in early life are an independent

190 ecome a useful diagnostic tool for bacterial respiratory infections in HIV-infected inpatients, but i

191 There are limited data on the etiology of respiratory infections in human immunodeficiency virus (

192 or produced by Bordetella species that cause respiratory infections in humans and other animals.

193 viruses are one of the most common causes of respiratory infections in humans, causing 1 billion infe

194 (IAVs) are one of the most common causes of respiratory infections in humans, resulting in thousands

195 s (IAVs) are among the most common causes of respiratory infections in humans.

196 yxovirus that causes deadly encephalitis and respiratory infections in humans.

197 ant risk factor in the development of severe respiratory infections in infants and young children.

198 piratory syncytial virus (RSV) causes severe respiratory infections in infants, young children, and t

199 eir combinations were used to cause systemic/respiratory infections in mice.

200 Respiratory infections in the postacute phase of traumat

201 2 to 4.4]; P = .10); 679 laboratory-detected respiratory infections in the respirator group vs 745 in

202 y viruses associated with clusters of severe respiratory infections in Uganda.

203 t common viruses associated with acute lower respiratory infections in young children (<5 years) and

204 reased risk of complications following viral respiratory infections, including increased morbidity, m

205 tis may relate to maternal factors and early respiratory infections independent of atopy.

206 n for skin and soft-tissue infection (SSTI), respiratory infection, intra-abdominal infection, or uri

207 sting is essential component of severe acute respiratory infection investigation for at-risk patients

208 ry syncytial virus (RSV)-related acute lower respiratory infection is an important cause of death in

209 associated with SARS-CoV-2 in patients whose respiratory infection is mild or asymptomatic might prov

210 The spread of many respiratory infections is determined by contact patterns

211 Rapid and definitive diagnosis of viral respiratory infections is imperative in patient triage a

212 ute respiratory illness, laboratory-detected respiratory infections, laboratory-confirmed respiratory

213 As in other respiratory infections, leukocyte recruitment to the res

214 s infection among children hospitalized with respiratory infections likely increased deaths due to me

215 erate, or high risk for progression to lower respiratory infection (LRI) or death.

216 Viruses are frequent causes of lower respiratory infection (LRI).

217 Lower respiratory infections (LRIs) are the leading cause of d

218 rd for clinical diagnosis of bacterial lower respiratory infections (LRIs) is culture, which has poor

219 However, during acute viral lower respiratory infection, lung TCD8 are functionally impair

220 s between early-life exposures (infant lower respiratory infection, manual social class, home overcro

221 major cause of childhood medically attended respiratory infection (MARI).

222 hogens in gastrointestinal, bloodstream, and respiratory infections may be used.

223 iddle East respiratory syndrome severe acute respiratory infection (median [quartile 1, quartile 3] 5

224 ed mouse models of Chlamydia and Haemophilus respiratory infection-mediated, ovalbumin-induced severe

225 Using a mouse respiratory infection model, we show that clinical isola

226 reduced B. ambifaria persistence in a murine respiratory infection model.

227 enza death across countries by comparing GHE respiratory infection mortality rates from countries wit

228 ears) using WHO Global Health Estimate (GHE) respiratory infection mortality rates.

229 Usually considered as a mild respiratory infection, Mp was the most commonly detected

230 children (<=3 years) hospitalized with viral respiratory infection (n = 138) and in uninfected contro

231 iddle East respiratory syndrome severe acute respiratory infection (n = 330) admitted between Septemb

232 , pericardial effusion (n=2 [3%]), and upper respiratory infection (n=2 [3%]).

233 237,833), pneumonia (n = 52,946), and upper respiratory infections (n = 414,556).

234 ost common grade >=3 adverse events included respiratory infections (n = 4; 18%) and atrial fibrillat

235 iddle East respiratory syndrome severe acute respiratory infection) (n = 222).

236 Malaria, lower respiratory infections, neonatal disorders, diarrhoeal d

237 atients with community-acquired severe acute respiratory infection of non-Middle East respiratory syn

238 n of MeV-specific T cells for 6 months after respiratory infection of rhesus macaques with wild type

239 S. maltophilia were assessed in experimental respiratory infections of mice.

240 ronaviridae family of viruses that can cause respiratory infections of varying severity.

241 for the large-scale, real-time detection of respiratory infections, often pre-symptomatically.

242 e epidemiology of hospitalizations for acute respiratory infection or febrile illness (ARFI) and infl

243 a, bronchitis, bronchiolitis, a wheezy lower respiratory infection or fever and cough.

244 CI, 1%-38%; I2 = 0%; N = 1903) against acute respiratory infections or influenza-like illness.

245 disease-specific or other entities, such as respiratory infections or pollution, are responsible.

246 In 1990, 16 of 33 provinces had lower respiratory infections or preterm birth complications as

247 (OR = 1.013; 95% CI: 1.003, 1.023) and upper respiratory infections (OR = 1.015; 95% CI: 1.008, 1.022

248 eek of life is associated with the number of respiratory infections over the first year.

249 ergistic interactions of smoking with infant respiratory infection (P = 0.04) and early-life home ove

250 e LTL reducing SNP rs7253490 associates with respiratory infections (P = 7.44 x 10(-4)) although this

251 iddle East respiratory syndrome severe acute respiratory infection patients were younger than those w

252 Evidence on mask effectiveness for respiratory infection prevention is stronger in health c

253 the typical clinical syndrome of viral upper respiratory infection progressing to the lower respirato

254 The ability to diagnose respiratory infections rapidly and close to the patient

255 influenza, pneumonia, and unspecified upper respiratory infections) recorded in ambulatory visits fr

256 antibiotic treatment in patients with acute respiratory infections reduces antibiotic exposure and s

257 ffector T cells (increased susceptibility to respiratory infection) remains unclear.

258 rsening dyspnea, influenza, pneumonia, other respiratory infections, respiratory failure, or airway e

259 e animals after intravenous infection, while respiratory infection results in virus replication in th

260 n and 40 children with unexplained recurrent respiratory infections, revealing age-dependent variatio

261 rotective effects of BCG vaccination against respiratory infection (RI) and sepsis not attributable t

262 ys fail to control IAV and succumb to lethal respiratory infection, RIPK3-mediated apoptosis by itsel

263 Respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) constitutes a substantia

264 y to syndromic surveillance for severe acute respiratory infection (SARI) in Uganda by combining spat

265 included postextubation respiratory failure, respiratory infection, sepsis and multiorgan failure, IC

266 Secondary outcomes included respiratory infection, sepsis, and multiple organ failur

267 uded decannulation failure, weaning failure, respiratory infections, sepsis, multiorgan failure, dura

268 at increased risk for severe morbidity from respiratory infections such as influenza.

269 is infection, tuberculosis disease, or acute respiratory infection than placebo among vitamin D-defic

270 se of 2019 (COVID-19) is a highly contagious respiratory infection that is caused by the severe acute

271 and assortative contact patterns relevant to respiratory infections, the model's age stratification i

272 ials in patients with coronavirus-associated respiratory infections, there is a paucity of data to su

273 ifficulty breathing, apnea or upper or lower respiratory infection through 8 weeks of age.

274 ocalcitonin protocols in patients with acute respiratory infections thus has the potential to improve

275 at cause disease in humans ranging from mild respiratory infection to potentially lethal acute respir

276 The response of respiratory infections to source-specific particulate ma

277 Viral respiratory infections trigger severe exacerbations of a

278 is is a frequent complication of viral upper respiratory infection (URI).

279 Viral upper respiratory infections (URIs) are common and often preci

280 tient antibiotic prescribing for acute upper respiratory infections (URIs) is a high-priority target

281 ountries with high rates of mortality due to respiratory infection using the same methods.

282 /182 prescriptions), while it was non-severe respiratory infections using the control algorithm (ALMA

283 Index score, chronic kidney disease, cancer, respiratory infection, vasoactive agent use, and receipt

284 An acute lower respiratory infection was defined as a diagnosis of pneu

285 Antecedent upper respiratory infection was documented in 15 of 66 patient

286 Care for hospitalized patients with viral respiratory infections was observed in the patient room

287 inhibitors of HPIV3 (a major cause of acute respiratory infection), we identified GHP-88309-a non-nu

288 or in vivo 25(OH)D status to increased viral respiratory infections, we poorly understand how vitamin

289 Patients presenting with acute respiratory infection were enrolled and tested for respi

290 Data on deaths from lower respiratory infection were obtained from death certifica

291 ED visits for asthma or wheeze and for upper respiratory infections were associated with PM2.5 concen

292 ient data from trials in which patients with respiratory infections were randomly assigned to receive

293 with oral amoxicillin) of suspected neonatal respiratory infections, were linked with traditional bir

294 to improve clinical outcome in children with respiratory infections while substantially reducing anti

295 ed on a persistent type 2 immune response to respiratory infection with a natural pathogen (Sendai vi

296 Early-life wheezing-associated respiratory infection with human rhinovirus (RV) is asso

297 Acute respiratory infection with mouse adenovirus type 1 (MAV-

298 ginosa This is to be contrasted with chronic respiratory infection with P. aeruginosa, suggesting tha

299 ve Pneumocystis to elicit protection against respiratory infection with Pneumocystis murina.

300 mice lacking B cells were more resistant to respiratory infection with vaccinia virus than wild-type